Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

by | Dec 26, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Read More

You must be logged in to post a comment.